福建师范大学学报(自然科学版)2026,Vol.42Issue(5):78-88,11.DOI:10.12046/j.issn.1000-5277.2026050009
抗肿瘤纳米药物的器官选择性靶向机制与研究进展
Organ-selective targeting mechanisms and research advances in antitumor nanomedicines
摘要
Abstract
Malignant tumors remain a major threat to human health,and conventional therapies are often associated with significant toxic side effects due to their lack of selectivity.Nanocarriers provide a promising strategy for precise drug delivery;however,low in vivo delivery efficiency and nonspecific accumulation remain major obstacles to their clinical translation.In recent years,organ-selective targeting has emerged as an important approach to overcoming these bottlenecks,as it can elevate local drug concentrations at lesion sites while reducing systemic toxicity.This review system-atically summarizes the key physiological barriers encountered during in vivo nanomedicine delivery and the mechanisms for overcoming these barriers,with a focus on the structural features of different organs and the corresponding targeting strategies.Representative research advances in organ-selec-tive antitumor nanomedicines in recent years are also outlined.On this basis,future development directions,including the synergistic overcoming of multiple barriers and artificial intelligence-assisted design,are discussed,aiming to provide a reference for research and clinical translation in this field.关键词
抗肿瘤纳米药物/器官选择性靶向/递送屏障/靶向策略/纳米药物设计Key words
antitumor nanomedicines/organ-selective targeting/delivery barriers/targeting strategies/nanomedicine design分类
医药卫生引用本文复制引用
雷泽宇,林晨煜,彭海豹..抗肿瘤纳米药物的器官选择性靶向机制与研究进展[J].福建师范大学学报(自然科学版),2026,42(5):78-88,11.基金项目
国家自然科学基金项目(62475047) (62475047)